Cargando…

Efficacy of Boron Neutron Capture Therapy in Primary Central Nervous System Lymphoma: In Vitro and In Vivo Evaluation

Background: Boron neutron capture therapy (BNCT) is a nuclear reaction-based tumor cell-selective particle irradiation method. High-dose methotrexate and whole-brain radiation therapy (WBRT) are the recommended treatments for primary central nervous system lymphoma (PCNSL). This tumor responds well...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Kohei, Kawabata, Shinji, Kashiwagi, Hideki, Fukuo, Yusuke, Takeuchi, Koji, Futamura, Gen, Hiramatsu, Ryo, Takata, Takushi, Tanaka, Hiroki, Watanabe, Tsubasa, Suzuki, Minoru, Hu, Naonori, Miyatake, Shin-Ichi, Wanibuchi, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699713/ https://www.ncbi.nlm.nih.gov/pubmed/34943904 http://dx.doi.org/10.3390/cells10123398

Ejemplares similares

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

ET-4 BASIC RESEARCH OF BORON NEUTRON CAPTURE THERAPY USING A NOVEL BORON COMPOUND TARGETED TO INTEGRIN
por: Tsujino, Kohei, et al.
Publicado: (2022)

TB-6 Experimental evaluation of the therapeutic potential of boron neutron capture therapy in primary central nervous system lymphoma
por: Yoshimura, Kohei, et al.
Publicado: (2021)

Evaluation of the Effectiveness of Boron Neutron Capture Therapy with Iodophenyl-Conjugated closo-Dodecaborate on a Rat Brain Tumor Model
por: Fujikawa, Yoshiki, et al.
Publicado: (2023)

Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model
por: Kashiwagi, Hideki, et al.
Publicado: (2023)

Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model
por: Tsujino, Kohei, et al.
Publicado: (2023)

ET-5 Biological effects of simultaneous use of multiple drugs in neutron capture therapy using rat brain tumor model
por: Kawabata, Shinji, et al.
Publicado: (2021)

Synthesis and Evaluation of Dodecaboranethiol Containing Kojic Acid (KA-BSH) as a Novel Agent for Boron Neutron Capture Therapy
por: Takeuchi, Koji, et al.
Publicado: (2020)

5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
por: Fukumura, Masao, et al.
Publicado: (2023)

ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019)

RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
por: Takai, Satoshi, et al.
Publicado: (2021)

Proposal of recommended experimental protocols for in vitro and in vivo evaluation methods of boron agents for neutron capture therapy
por: Hattori, Yoshihide, et al.
Publicado: (2023)

TB-03 THE SURVIVAL PROLONGATION EFFECT OF NOVEL BORON COMPOUND FOR BNCT USING RAT BRAIN TUMOR MODEL
por: Fukuo, Yusuke, et al.
Publicado: (2019)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET
por: Takai, Satoshi, et al.
Publicado: (2020)

Development of optimization method for uniform dose distribution on superficial tumor in an accelerator-based boron neutron capture therapy system
por: Sasaki, Akinori, et al.
Publicado: (2023)

Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma
por: Futamura, Gen, et al.
Publicado: (2017)

Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
por: Hiramatsu, Ryo, et al.
Publicado: (2013)

Microdosimetric quantities of an accelerator-based neutron source used for boron neutron capture therapy measured using a gas-filled proportional counter
por: Hu, Naonori, et al.
Publicado: (2020)

Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018)

A Case of Puncture-Site Giant Pseudoaneurysm Following Recanalization Therapy for Acute Ischemic Stroke: Marked Growth and Rupture of a Femoral Artery Pseudoaneurysm
por: Matsubara, Noriaki, et al.
Publicado: (2021)

The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model
por: Takahara, Kiyoshi, et al.
Publicado: (2015)

10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT
por: Miyatake, Shin-Ichi, et al.
Publicado: (2020)

Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan
por: Matsumura, Akira, et al.
Publicado: (2023)

Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies
por: Monti Hughes, Andrea, et al.
Publicado: (2023)

The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2014)

Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy
por: Watanabe, Tsubasa, et al.
Publicado: (2022)

Improvement in the neutron beam collimation for application in boron neutron capture therapy of the head and neck region
por: Hu, Naonori, et al.
Publicado: (2022)

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer
por: Suzuki, Minoru, et al.
Publicado: (2014)

The impact of TP53 status of tumor cells including the type and the concentration of administered (10)B delivery agents on compound biological effectiveness in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2023)

Analysis of boron neutron capture reaction sensitivity using Monte Carlo simulation and proposal of a new dosimetry index in boron neutron capture therapy
por: Takeno, Satoshi, et al.
Publicado: (2022)

Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1998)

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
por: Barth, Rolf F, et al.
Publicado: (2012)

Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021)

HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex
por: Yamana, Keita, et al.
Publicado: (2023)

Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis
por: MASUNAGA, SHIN-ICHIRO, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_id2rsfml4o54qs9e997q2rjqum